<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2310234374
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TISSEEL Lyo Powder And Solvent For Sealant
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HUMAN FIBRINOGEN,APROTININ,HUMAN THROMBIN,CALCIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        72-110,2250-3750,400-625,36-44
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Epilesional use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder and solvent for sealant
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        2195.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TAKEDA MANUFACTURING AUSTRIA AG" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TAKEDA MANUFACTURING AUSTRIA AG
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Medical Products GmbH 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B02BC10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What </strong><strong>TISSEEL Lyo&nbsp;is</strong></p><p>The name of your medicine is TISSEEL Lyo.</p><p>TISSEEL Lyo is a two-component fibrin sealant, and it contains two of the proteins that make blood clot. These proteins are called fibrinogen and thrombin. When these proteins mix during application, they form a clot where the surgeon applies them.</p><p>TISSEEL Lyo is prepared as two solutions, which mix when applied.</p><p>&nbsp;</p><p><strong>What </strong><strong>TISSEEL Lyo&nbsp;is used for</strong></p><p>TISSEEL Lyo is a fibrin sealant. During surgery, tissues may bleed or ooze, and it may not be possible for the surgeon to control this bleeding using stitches, or by applying pressure. TISSEEL Lyo is applied to tissues either to control bleeding, or to stop (or prevent) leaks of other types of fluid by creating a watertight seal.</p><p>TISSEEL Lyo can be used even if your blood does not clot properly, such as occurs when you are treated with heparin. It is also used as a tissue glue to achieve adhesion/sealing or as suture support in surgery. In addition, TISSEEL Lyo is used to fix mesh during hernia repair surgery.</p><p>The clot produced by TISSEEL Lyo is very similar to a natural blood clot and this means that it will dissolve naturally and leave no residue. However, synthetic aprotinin is added to increase the longevity of the clot and to prevent its premature dissolution.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use TISSEEL Lyo: </strong></p><p>Certain people should avoid receiving TISSEEL Lyo. If any of the following apply to you, you should tell your doctor.</p><ul><li>Have you reacted to drugs or other products produced from cattle?</li><li>Have you ever suffered from a reaction to any of the products listed in the ingredients of this medicine?</li></ul><p>TISSEEL Lyo is not suitable on its own for treating active or spurting bleeding from arteries or veins. It is not to be applied inside blood vessels.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><ul><li><strong>Life-threatening/fatal air or gas embolism (air getting into the blood circulation which can be serious or life-threatening) has occurred very rarely with the use of spray devices employing pressure regulators to administer fibrin sealants. This appears to be related to the use of the spray device at higher than recommended pressures and/or in close proximity to the tissue surface. The risk appears to be higher when fibrin sealants are sprayed with air, as compared to CO2 and therefore cannot be excluded with TISSEEL Lyo when sprayed in open wound surgery.Take special care with TISSEEL Lyo&nbsp;because allergic hypersensitivity reactions may occur.</strong></li><li><strong>Spray devices and the accessory tip provide instructions for use with recommendations for pressure ranges and to the spraying distance from the tissue surface.</strong></li><li><strong>TISSEEL Lyo should be administered strictly according to the instructions and only with devices recommended for this product.</strong></li><li><strong>When spraying TISSEEL Lyo, changes in blood pressure, pulse, oxygen saturation and end tidal CO2 should be monitored for possible occurrence of gas embolism.</strong></li></ul><p>Certain people are very sensitive to medicines in general, and may react to TISSEEL Lyo being applied. If you think this applies to you, please discuss this with your doctor.</p><p>TISSEEL Lyo MUST NOT be injected into blood vessels (veins or arteries), or into tissues. As TISSEEL Lyo forms a clot where it is applied, injecting TISSEEL Lyo may cause serious reactions. TISSEEL Lyo should only be applied to the surface of tissues as thin layer where it is needed.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TISSEEL Lyo contains a synthetic protein, called aprotinin. Even when this protein is applied in small areas, there is a risk of a reaction known as anaphylaxis, or a severe allergic reaction. This risk is increased in patients who have received aprotinin before, even if there was no reaction to the first application. It is very important that the hospital staff who treat you record in your notes when you have received aprotinin, or TISSEEL Lyo</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever received TISSEEL Lyo or aprotinin before, your body may have become sensitive to it, and it is possible you have an allergy. If you think you have received either product in a previous operation, please talk to your doctor about this.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the surgeon or operating team sees any sign of an allergic reaction when they apply TISSEEL, the use of TISSEEL Lyo should be stopped immediately. Early symptoms of allergic reactions can be: flushing, a fall in blood pressure, increased or decreased pulse rate, nausea (feeling sick), hives, itching, difficulty breathing.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TISSEEL Lyo must NOT be injected into blood vessels (veins or arteries), or into tissues. As TISSEEL Lyo forms a clot where it is applied, injecting TISSEEL Lyo may cause serious complications. TISSEEL Lyo should only be applied to the surface where it is needed. In particular your surgeon should apply TISSEEL Lyo with special care if you are having coronary bypass surgery (surgery to replace diseased arteries) to minimize the risk of the product going into your blood vessels</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Some solutions that contain alcohol, iodine or certain types of metals (these are normally found in disinfectants or antiseptics) may reduce the ability of TISSEEL Lyo to work normally. These substances should be removed, as far as possible, before TISSEEL Lyo is applied.</p><p>TISSEEL Lyo is made from the plasma taken from blood donations. When medicinal products prepared from human blood or plasma are administered, the transmission of infections (or diseases) cannot be totally ruled out. This applies to diseases we already know about and also those that have not yet been discovered.</p><p>&nbsp;</p><p>To reduce the risk of infections being transmitted, donors are selected very carefully, and all donations are tested. Each donation is tested to ensure that the donor is not infected with HIV (the virus that causes AIDS), or the viruses Hepatitis A, B or C (that cause liver disease).</p><p>&nbsp;</p><p>As a further safety measure, there are processes during manufacturing that are designed to remove or kill viruses in the raw materials. However, these methods are not completely effective against Parvovirus B19 &ndash; it is still possible that these diseases could be transmitted if they were present in the original plasma donation.</p><p>&nbsp;</p><p>In healthy people, Parvovirus B19 infection can cause a mild illness which may result in a facial rash which lasts for about a week. It may also cause joint pain which can last for a few weeks, but it is not harmful to the joints themselves. In people with immune deficiencies (when the immune system does not make antibodies properly), the virus can cause chronic anaemia &ndash; this can be controlled or cured by treatment with other medicines. If a pregnant woman is infected with Parvovirus B19, there is a small risk (less than one in ten) of it causing a miscarriage. Most adults carry antibodies to Parvovirus B19.</p><p>&nbsp;</p><p>It is strongly recommended that the hospital staff who treat you record the name and batch number of the product in your notes.</p><p>&nbsp;</p><p><strong>Other medicines and TISSEEL Lyo </strong></p><p>It is not thought that TISSEEL Lyo affects the action of other drugs, however you should always tell your doctor about any medicines or dietary supplements you are taking (for example, vitamins, St John&rsquo;s Wort), even those you have bought yourself from a chemist or supermarket.</p><p>&nbsp;</p><p>Oxidised cellulose containing preparations may reduce the efficacy of TISSEEL Lyo and should not be used as carrier materials.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will decide if you can use TISSEEL during pregnancy or breast-feeding.</p><p>&nbsp;</p><p>The effects of TISSEEL Lyo on fertility have not been established. Please see Section 2 regarding the risks of Parvovirus B19 during pregnancy.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>As you will be in hospital when TISSEEL Lyo is applied, it is not possible for TISSEEL Lyo to affect your ability to drive or operate other types of machine.</p><p>&nbsp;</p><p><strong>Important information about some of the ingredients of TISSEEL Lyo</strong></p><p>Polysorbate 80 may cause locally limited skin irritations such as contact dermatitis.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><ul><li>TISSEEL Lyo is only applied during a surgical operation. The use of TISSEEL Lyo is restricted to experienced surgeons who have been trained in the use of TISSEEL Lyo.</li></ul><p>&nbsp;</p><p>The amount of TISSEEL Lyo that will be used depends on a number of factors, including but not limited to the type of surgery, the surface area of tissue to be treated during your operation and the way TISSEEL Lyo is applied. The surgeon will decide how much is appropriate, and will apply just enough to form a thin, even layer over the tissue. If this does not seem to be enough, a second layer can be applied. However, avoid a reapplication of TISSEEL Lyo to a pre-existing polymerized TISSEEL Lyo layer as TISSEEL Lyo will not adhere to a polymerized layer. Separate, sequential application of the two components of TISSEEL Lyo must be avoided.</p><p>&nbsp;</p><ul><li>During your operation the surgeon will apply TISSEEL Lyo onto the relevant tissue surface, using the special application device provided. This device ensures that equal amounts of both components are applied at the same time &ndash; this is important for TISSEEL Lyo to have its optimal effect.</li><li>For hernia mesh repair the surgeon will apply TISSEEL using spray or drops to fix the mesh in place.</li><li>Specially trained staff from Baxter Healthcare will have trained the theatre nurses and the surgeon in how to prepare and use TISSEEL Lyo properly, before your operation takes place.</li><li>Prior to applying TISSEEL Lyo the surface area of the wound needs to be dried by standard techniques (e.g. intermittent application of compresses, swabs, use of suction devices).</li><li>Pressurised air or gas must not be used for drying the site.</li></ul><ul><li>TISSEEL must be sprayed only onto application sites that are visible.</li></ul><p>&nbsp;</p><p><strong><u>When applying TISSEEL Lyo using a spray device be sure to use a pressure and a distance from the tissue within the range recommended by the manufacturer as follows:</u></strong></p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:686px"><tbody><tr><td colspan="6" style="width:683px"><p style="text-align:center"><strong>Recommended pressure, distance and devices for spray application of TISSEEL Lyo</strong></p></td></tr><tr><td><p style="text-align:center">Surgery</p></td><td style="width:110px"><p style="text-align:center">Spray set to be used</p></td><td style="width:129px"><p style="text-align:center">Applicator tips to be used</p></td><td style="width:115px"><p style="text-align:center">Pressure regulator to be used</p></td><td style="width:134px"><p style="text-align:center">Recommended distance from target tissue</p></td><td style="width:121px"><p style="text-align:center">Recommended spray&nbsp; pressure</p></td></tr><tr><td rowspan="2"><p style="text-align:center">Open wound</p></td><td style="vertical-align:top; width:110px"><p style="text-align:center">TISSEEL / Artiss Spray Set</p></td><td style="width:129px"><p style="text-align:center">n.a.</p></td><td style="width:115px"><p style="text-align:center">EasySpray</p></td><td rowspan="2" style="width:134px"><p style="text-align:center">10-15cm</p></td><td rowspan="2" style="width:121px"><p style="text-align:center">1.5-2.0 bar<br />(21.5-28.5 psi).</p></td></tr><tr><td style="vertical-align:top; width:110px"><p style="text-align:center">TISSEEL / Artiss Spray Set 10 pack</p></td><td style="width:129px"><p style="text-align:center">n.a.</p></td><td style="width:115px"><p style="text-align:center">EasySpray</p></td></tr><tr><td colspan="6" style="vertical-align:top; width:683px"><p style="text-align:center">&nbsp;</p></td></tr><tr><td rowspan="6"><p style="text-align:center">Laparoscopic/ minimally invasive procedures</p></td><td rowspan="6" style="width:110px"><p style="text-align:center">n.a.</p></td><td style="width:129px"><p style="text-align:center">Duplospray MIS Applicator 20cm</p></td><td rowspan="6" style="width:115px"><p style="text-align:center">Duplospray MIS Regulator 1.5 bar</p><p style="text-align:center">&nbsp;</p></td><td rowspan="6" style="width:134px"><p style="text-align:center">2-5 cm</p></td><td rowspan="6" style="width:121px"><p style="text-align:center">1.2-1.5 bar</p><p style="text-align:center">(18-22 psi)</p></td></tr><tr><td style="width:129px"><p style="text-align:center">Duplospray MIS Applicator 30cm</p></td></tr><tr><td style="width:129px"><p style="text-align:center">Duplospray MIS Applicator 40cm</p></td></tr><tr><td style="width:129px"><p style="text-align:center">Spray Set 360 Endoscopic Applicator with Snaplock</p></td></tr><tr><td style="width:129px"><p style="text-align:center">Spray Set 360 Endoscopic Applicator with Tether</p></td></tr><tr><td style="width:129px"><p style="text-align:center">Replaceable tip</p></td></tr></tbody></table><p style="text-align:center"><strong>&nbsp;</strong></p><p style="text-align:center"><strong>&nbsp;</strong></p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>When spraying the TISSEEL Lyo, changes in blood pressure, pulse, oxygen saturation and end tidal CO<sub>2 </sub>should be monitored because of the possibility of occurrence of air or gas embolism <u>(see section 2)</u>.</strong></p><p>&nbsp;</p><p><strong>If you take more TISSEEL than you should </strong></p><p>As TISSEEL Lyo is only ever applied by a surgeon, we do not think it is possible to use too much.</p><p>&nbsp;</p><p><strong>Use in children</strong></p><p>Safety and efficacy of the product in children have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.&nbsp; If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p><p>Side effects have been evaluated on the basis of the following frequency categories:</p><p><strong>&nbsp;</strong></p><p><strong>Very common</strong>: Affects more than 1 in 10.</p><p><strong>Common</strong>: Affects 1 to 10 users in 100.</p><p><strong>Uncommon</strong>: Affects 1 to 10 users in 1,000.</p><p><strong>Rare</strong>: Affects 1 to 10 users in 10,000.</p><p><strong>Very rare</strong>: Affects fewer than 1 out of 10,000 patients treated.</p><p><strong>Not known</strong>: The frequency cannot be estimated from the available data.</p><p><strong>&nbsp;</strong></p><p><strong>The following side effects have been observed in treatment with TISSEEL Lyo:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:623px"><tbody><tr><td><p><strong>General areas </strong></p></td><td><p><strong>Side Effect</strong></p></td><td><p><strong>Frequency</strong></p></td></tr><tr><td><p>Infections and parasitic diseases</p></td><td><p>Postoperative wound infection</p></td><td><p>Common</p></td></tr><tr><td><p>Blood and lymphatic system disorders</p></td><td><p>Increase of fibrin degradation products</p></td><td><p>Uncommon</p></td></tr><tr><td rowspan="8"><p>Immune system disorders</p></td><td><p>Hypersensitivity reactions</p></td><td><p>Not known</p></td></tr><tr><td><p>Allergic (anaphylactic) reactions</p></td><td><p>Not known</p></td></tr><tr><td><p>Anaphylactic shock</p></td><td><p>Not known</p></td></tr><tr><td><p>Sensation of tingling, pricking or numbness of the skin</p></td><td><p>Not known</p></td></tr><tr><td><p>Tightness of the chest</p></td><td><p>Not known</p></td></tr><tr><td><p>Breathing difficulties</p></td><td><p>Not known</p></td></tr><tr><td><p>Itching</p></td><td><p>Not known</p></td></tr><tr><td><p>Reddening of the skin</p></td><td><p>Not known</p></td></tr><tr><td><p>Nervous system disorders</p></td><td><p>Sensory disturbance</p></td><td><p>Common</p></td></tr><tr><td><p>Cardiac disorders</p></td><td><p>Increase or drop in pulse rate</p></td><td><p>Not known</p></td></tr><tr><td rowspan="6"><p>Vascular disorders</p></td><td><p>Axillary venous thrombosis</p></td><td><p>Common</p></td></tr><tr><td><p>Drop in blood pressure</p></td><td><p>Rare</p></td></tr><tr><td><p>Bruising</p></td><td><p>Not known</p></td></tr><tr><td><p>Gas bubbles in the vascular system*</p></td><td><p>Not known</p></td></tr><tr><td><p>Blood clot in blood vessels</p></td><td><p>Not known</p></td></tr><tr><td><p>Blockage of an artery in the brain</p></td><td><p>Not known</p></td></tr><tr><td><p>Respiratory, and thoracic disorders</p></td><td><p>Dyspnoea</p></td><td><p>Uncommon</p></td></tr><tr><td rowspan="2"><p>Gastrointestinal disorders</p></td><td><p>Nausea</p></td><td><p>Uncommon</p></td></tr><tr><td><p>Intestinal obstruction</p></td><td><p>Not known</p></td></tr><tr><td rowspan="3"><p>Skin and subcutaneous tissue disorders</p></td><td><p>Skin Rash</p></td><td><p>Common</p></td></tr><tr><td><p>Hives</p></td><td><p>Not known</p></td></tr><tr><td><p>Impaired healing</p></td><td><p>Not known</p></td></tr><tr><td><p>Musculoskeletal and connective tissue disorders</p></td><td><p>Pain in extremities</p></td><td><p>Common</p></td></tr><tr><td rowspan="5"><p>General disorders and administration site conditions</p></td><td><p>Pain caused by the procedure</p></td><td><p>Uncommon</p></td></tr><tr><td><p>Pain</p></td><td><p>Common</p></td></tr><tr><td><p>Increased body temperature</p></td><td><p>Common</p></td></tr><tr><td><p>Reddening of the skin</p></td><td><p>Not known</p></td></tr><tr><td><p>Swelling through the accumulation of fluid in the body tissue (oedema)</p></td><td><p>Not known</p></td></tr><tr><td rowspan="2"><p>Injury, poisoning and procedural complications</p></td><td><p>Accumulation of lymph or other clear bodily fluids near the operation site (seroma)</p></td><td><p>Very common</p></td></tr><tr><td><p>Rapid swelling of dermis, subcutaneous tissue, mucosa and submucosa (angioedema)</p></td><td><p>Not known</p></td></tr></tbody></table><p>&nbsp;* the introduction of air or gas bubbles in the vascular system have occurred when fibrin sealants are applied with devices using pressurized air or gas; this is believed to be caused by inappropriate use of the spray device (e.g. at higher than recommended pressure and in close proximity to the tissue surface.)</p><p>&nbsp;</p><p>In isolated cases, these reactions may progress to severe allergic reactions (anaphylaxis). Such reactions may be seen especially if the preparation is applied repeatedly, or administered to patients who have previously shown hypersensitivity to aprotinin or any other component of the product.</p><p>&nbsp;</p><p>Even if repeated treatment with TISSEEL Lyo was well tolerated, a subsequent administration of TISSEEL Lyo or an infusion of aprotinin may result in severe allergic (anaphylactic) reactions.</p><p>&nbsp;</p><p>The attending surgical team is well aware of the risk of reactions of this type and will immediately interrupt the application of TISSEEL Lyo on the occurrence of the first signs of hypersensitivity. In the case of severe symptoms emergency measures may be required.</p><p>&nbsp;</p><p>The injection of TISSEEL Lyo into soft tissues may lead to local tissue damage.</p><p>&nbsp;</p><p>The injection of TISSEEL Lyo into blood vessels (veins or arteries) may lead to the formation of clots (thromboses).</p><p>&nbsp;</p><p>Intravascular application might increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients.</p><p>&nbsp;</p><p>As TISSEEL Lyo is derived from plasma from blood donations, the risk of an infection cannot be excluded completely. However, the manufacturers take numerous measures to reduce this risk (see section 2).</p><p>&nbsp;</p><p>Antibodies against components of the fibrin sealant may occur in rare cases.</p><p>&nbsp;</p><p>If you feel unwell after your operation, and the symptoms do not match those that your doctor has already told you about, then you should speak to your doctor immediately.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance Centre (NPC)</p><ul><li>SFDA Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul></td></tr></tbody></table><p>&nbsp;</p><ul><li><strong>Other GCC States:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><ul><li>Please contact the relevant competent authority.</li></ul></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Keep out of the sight and reach of children.</li><li>Store at 2&deg;C to 25&deg;C. Do not freeze.</li><li>Store in the original package in order to protect from light.</li><li>Do not use after the expiry date stated on the label.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What TISSEEL Lyo&nbsp;contains</strong></p><p><strong>&nbsp;</strong></p><p>When prepared, 1 ml of each solution contains the following:</p><p><strong>&nbsp;</strong></p><p><strong>Component 1: Sealer protein solution </strong></p><p><strong>&nbsp;</strong></p><p>The active substances are human fibrinogen (as clottable protein), 72-110 mg in 96-125 mg protein; aprotinin (synthetic), 3000 KIU per ml. The other ingredients are human albumin, L-Histidine, niacinamide, polysorbate 80, sodium citrate dihydrate and water for injections.The other ingredient is: Water for Injections.</p><p>&nbsp;</p><p><strong>Component 2: Thrombin solution</strong></p><p><strong>&nbsp;</strong></p><p>The active substances are human thrombin, 500 IU, in 45-55 mg protein; calcium chloride dihydrate, 40 micromol/litre. The other ingredients are human albumin, sodium chloride and water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                All components of TISSEEL Lyo are filled into glass containers.
The freeze-dried components are white or slightly yellowish and have a powdery or granular consistency; the liquid components are colorless or slightly yellowish.

TISSEEL is available in pack sizes of 2 ml, 4 ml and 10 ml. Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong>:<strong> </strong></p><p><strong>Baxter Medical Products GmbH</strong></p><p>Stella-Klein-L&ouml;w-Weg 15</p><p>1020 Vienna</p><p>Austria</p><p><strong>&nbsp;</strong></p><p><strong>Manufacturer</strong>:</p><p><strong>Takeda Manufacturing Austria AG</strong></p><p>Industriestrasse 67</p><p>1221 Vienna</p><p>Austria</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                November 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>ما هو </strong><strong>TISSEEL Lyo</strong><strong> </strong></p><p dir="RTL">اسم الدواء الخاص بك هو TISSEEL Lyo.</p><p dir="RTL">TISSEEL Lyo هو لاصق فايبرين مُركَّب من مكوّنين، يحتوي على اثنين من البروتينات التي تعمل على تجلط الدم. تسمى هذه البروتينات الفيبرينوجين والثرومبين. عندما تمتزج هذه البروتينات أثناء الاستعمال، فإنها تشكل جلطة في المكان الذي يستعملها فيها الجراح.</p><p dir="RTL">يتم تحضير TISSEEL Lyo كمحلولين يتم مزجهما عند الاستعمال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>دواعي استعمال </strong><strong>TISSEEL Lyo</strong><strong> </strong></p><p dir="RTL">TISSEEL Lyo هو لاصق فايبرين. أثناء الجراحة، قد يحدث نزيف أو نضح بالأنسجة، وقد لا يتمكن الجراح من التحكم في هذا النزيف باستعمال الغُرز أو بالضغط. يتم وضع TISSEEL Lyo على الأنسجة إما للسيطرة على النزيف، أو لوقف (أو منع) تسرب أنواع أخرى من السوائل عن طريق إنشاء لصق مضاد للماء.</p><p dir="RTL">يمكن استعمال TISSEEL Lyo حتى إذا كان دمك لا يتجلط بالصورة المعتادة، كما يحدث عندما يتم علاجك بالهيبارين. كما أنه يُستعمل كغراء طبي للأنسجة لتحقيق الالتصاق / اللصق أو كدعم للخياطة في الجراحة. بالإضافة إلى ذلك، يتم استعمال TISSEEL Lyo لإصلاح الشبكة خلال جراحة تصحيح الفتق.</p><p dir="RTL">تشبه الجلطة الناتجة عن TISSEEL Lyo إلى حد بعيد جلطة الدم الطبيعية وهذا يعني أنها ستذوب بشكل طبيعي ولا تترك أي بقايا. ومع ذلك، يضاف الأبروتينين الاصطناعي لزيادة طول عمر الجلطة ومنع ذوبانها المبكر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يُحظر استعمال </strong><strong>TISSEEL Lyo</strong><strong>: </strong></p><p dir="RTL">يجب على بعض الأشخاص تجنب تلقي TISSEEL Lyo. إذا انطبق عليك أي مما يلي، يجب أن تخبر طبيبك.</p><ul><li dir="RTL">هل تفاعلتَ مع الأدوية أو المنتجات الأخرى الناتجة من الماشية؟</li><li dir="RTL">هل سبق أن عانيتَ من رد فعل تجاه أي من المنتجات المدرجة في مكونات هذا الدواء؟</li></ul><p dir="RTL">لا يُعد TISSEEL Lyo مناسبًا بمفرده لعلاج النزيف النشط أو المتدفق من الشرايين أو الأوردة. لا يجوز وضعه داخل الأوعية الدموية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><ul><li dir="RTL"><strong>نادرًا ما يحدث انصمام هوائي أو غازي مهدد للحياة / مميت (دخول الهواء إلى الدورة الدموية والذي يمكن أن يكون خطيرًا أو يهدد الحياة) مع استعمال أجهزة الرش التي تستخدم منظمات الضغط لإدارة لاصقات الفايبرين. يبدو أن هذا مرتبط باستعمال جهاز الرش عند ضغوط أعلى من الضغوط الموصى بها و / أو بالقرب من سطح الأنسجة. يبدو أن الخطر أعلى عند رش لاصقات الفايبرين بالهواء، مقارنةً بثاني أكسيد الكربون، وبالتالي لا يمكن استبعاده مع </strong><strong>TISSEEL Lyo</strong><strong> عند رشها في جراحة الجروح المفتوحة. توخ الحذر مع </strong><strong>TISSEEL Lyo</strong><strong> حيث قد تحدث تفاعلات فرط الحساسية التحسسية.</strong></li><li dir="RTL"><strong>توفر أجهزة الرش وطرف الملحق تعليمات للاستعمال مع توصيات لنطاقات الضغط ومسافة الرش من سطح الأنسجة.</strong></li><li dir="RTL"><strong>يجب أن يُستعمل </strong><strong>TISSEEL Lyo</strong><strong> بصرامة وفقًا للتعليمات وفقط مع الأجهزة الموصى بها لهذا المنتج.</strong></li><li dir="RTL"><strong>عند رش </strong><strong>TISSEEL Lyo</strong><strong>، يجب مراقبة التغيرات في ضغط الدم والنبض وتشبع الأكسجين وثاني أكسيد الكربون في نهاية الزفير لاحتمال حدوث انصمام غازي.</strong></li></ul><p dir="RTL">بعض الأشخاص حساسون جدًا للأدوية بشكل عام، وقد تصدر منهم ردود فعل عند وضع TISSEEL Lyo. إذا كنت تعتقد أن هذا ينطبق عليك، فيرجى مراجعة هذا الأمر مع طبيبك.</p><p dir="RTL">يجب عدم حقن TISSEEL Lyo في الأوعية الدموية (الأوردة أو الشرايين)، أو في الأنسجة. نظرًا لأن TISSEEL Lyo يشكّل جلطة في مكان وضعه، فقد يتسبب حقن TISSEEL Lyo في تفاعلات خطيرة. يجب استعمال TISSEEL Lyo فقط على سطح الأنسجة كطبقة رقيقة عند الحاجة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي TISSEEL Lyo على بروتين صناعي يسمى أبروتينين. حتى عندما يتم وضع هذا البروتين في مناطق صغيرة، فهناك خطر حدوث تفاعل يعرف باسم الحساسية المفرطة، أو رد فعل تحسسي شديد. يزداد هذا الخطر عند المرضى الذين تلقوا أبروتينين من قبل، حتى لو لم تكن هناك رد فعل عند الاستعمال لأول مرة. من المهم جدًا أن يقوم طاقم المستشفى الذي يعالجك بتسجيل ملاحظاتك بعد تلقي أبروتينين أو TISSEEL Lyo</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا سبق وتلقيتَ TISSEEL Lyo أو أبروتينين من قبل، فقد يكون جسمك قد أصبح حساسًا تجاهه، ومن المحتمل أن يكون لديك حساسية. إذا كنت تعتقد أنك تلقيت أيًا من المنتجين في عملية سابقة، فيرجى التحدث مع طبيبك حول هذا الأمر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا رأى الجراح أو فريق العمليات أي علامة على وجود رد فعل تحسسي عند استعمال TISSEEL، فيجب إيقاف استعمال TISSEEL Lyo على الفور. يمكن أن تكون الأعراض المبكرة لردود الفعل التحسسية: احمرار الوجه، وانخفاض ضغط الدم، وزيادة معدل النبض أو انخفاضه، والغثيان (الشعور بالغثيان)، والشرى، والحكّة، وصعوبة التنفس.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم حقن TISSEEL Lyo في الأوعية الدموية (الأوردة أو الشرايين)، أو في الأنسجة. نظرًا لأن TISSEEL Lyo يشكّل جلطة في مكان استعماله، فقد يتسبب حقن TISSEEL Lyo في حدوث مضاعفات خطيرة. يجب وضع TISSEEL Lyo فقط على السطح الذي يحتاج إليه. على وجه الخصوص، يجب على جرّاحك وضع TISSEEL Lyo بعناية خاصة إذا كنت تخضع لعملية جراحية لتغيير الشرايين التاجية (جراحة لاستبدال الشرايين المريضة) لتقليل مخاطر دخول المنتج إلى الأوعية الدموية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض المحاليل التي تحتوي على الكحول أو اليود أو أنواع معينة من المعادن (توجد عادة في المعقمات أو المطهرات) قد تقلل من قدرة TISSEEL Lyo على العمل بشكل طبيعي. يجب إزالة هذه المواد، بقدر الإمكان، قبل وضع TISSEEL Lyo.</p><p dir="RTL">يتكون TISSEEL Lyo من البلازما المأخوذة من تبرعات الدم. عندما يتم إعطاء المنتجات الطبية المحضرة من دم الإنسان أو البلازما، لا يمكن استبعاد انتقال العدوى (أو الأمراض) تمامًا. هذا ينطبق على الأمراض التي نعرفها بالفعل وكذلك تلك التي لم يتم اكتشافها بعد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لتقليل خطر انتقال العدوى، يتم اختيار المتبرعين بعناية فائقة، ويتم اختبار جميع التبرعات. يتم اختبار كل تبرع للتأكد أن المتبرع ليس مصابًا بفيروس نقص المناعة البشرية (الفيروس الذي يسبب الإيدز) أو فيروسات التهاب الكبد A أو B أو C (التي تسبب أمراض الكبد).</p><p dir="RTL">&nbsp;</p><p dir="RTL">كتدبير سلامة إضافي، تتم عمليات أثناء التصنيع وهي مصممة لإزالة الفيروسات داخل المواد الخام أو التخلص منها. ومع ذلك، فهذه الطرق ليست فعالة تمامًا ضد فيروس Parvovirus B19 - لا يزال من الممكن أن تنتقل هذه الأمراض إذا كانت موجودة في التبرع بالبلازما الأصلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في الأشخاص الأصحاء، يمكن أن تسبب عدوى فيروس Parvovirus B19 مرضًا خفيفًا قد يؤدي إلى ظهور طفح جلدي في الوجه يستمر لمدة أسبوع تقريبًا. قد يسبب أيضًا ألمًا في المفاصل يمكن أن يستمر لبضعة أسابيع، لكنه غير ضار بالمفاصل نفسها. في الأشخاص الذين يعانون من نقص المناعة (عندما لا يصنع الجهاز المناعي الأجسام المضادة بشكل صحيح)، يمكن للفيروس أن يسبب فقر الدم المزمن - يمكن السيطرة عليه أو علاجه عن طريق العلاج بأدوية أخرى. إذا كانت المرأة الحامل مصابة بفيروس Parvovirus B19، فهناك خطر ضئيل (أقل من واحد من كل عشرة) من تسببه في الإجهاض. يحمل معظم البالغين أجسامًا مضادة لفيروس Parvovirus B19.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يوصى بشدة أن يقوم طاقم المستشفى الذي يعالجك بتسجيل اسم المنتج ورقم دفعة المنتج في ملاحظاتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى و</strong><strong>TISSEEL Lyo</strong><strong> </strong></p><p dir="RTL">لا يُعتقد أن TISSEEL Lyo يؤثر على عمل الأدوية الأخرى، ولكن يجب عليك دائمًا إخبار طبيبك بأي أدوية أو مكملات غذائية تتناولها (على سبيل المثال، الفيتامينات، ونبتة سانت جون &quot;عشبة القديس يوحنا&quot;)، حتى تلك التي اشتريتها بنفسك من الصيدلي أو سوبر ماركت.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تقلل المستحضرات المحتوية على السليلوز المؤكسد فاعلية TISSEEL Lyo ويجب عدم استعمالها كمواد ناقلة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة والخصوبة</strong></p><p dir="RTL">إذا كنتِ حاملاً أو مرضعة، أو تعتقدين أنك حاملاً أو تخططين لإنجاب طفل، فاسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول هذا الدواء. سيقرر طبيبك ما إذا كان بإمكانك استعمال TISSEEL أثناء الحمل أو الرضاعة الطبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لم يتم إثبات وجود تأثيرات لـ TISSEEL Lyo على الخصوبة. يرجى مراجعة القسم 2 بخصوص مخاطر فيروس Parvovirus B19 خلال فترة الحمل.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة واستعمال الأجهزة والمعدات</strong></p><p dir="RTL">لأنك ستكون في المستشفى عند استعمال TISSEEL Lyo، فلا يمكن لـ TISSEEL Lyo التأثير على قدرتك على القيادة أو تشغيل أنواع أخرى من الأجهزة والمعدات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات مهمة حول بعض مكونات </strong><strong>TISSEEL Lyo</strong></p><p dir="RTL">قد يتسبب Polysorbate 80 في حدوث تهيج جلدي محدود محليًا مثل التهاب الجلد التماسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li dir="RTL">يُستعمل TISSEEL Lyo فقط أثناء العمليات الجراحية. يقتصر استعمال TISSEEL Lyo على ذوي الخبرة من الجراحين الذين تم تدريبهم على استعمال TISSEEL Lyo.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">تعتمد كمية TISSEEL Lyo التي سيتم استعمالها على عدد من العوامل، بما في ذلك على سبيل المثال لا الحصر نوع الجراحة، ومساحة سطح الأنسجة المراد علاجها أثناء العملية وطريقة استعمال TISSEEL Lyo. سيقرر الجراح المقدار المناسب، وسيطبق ما يكفي فقط لتشكيل طبقة رقيقة متساوية فوق الأنسجة. إذا لم يبدو ذلك كافيًا، فيمكن وضع طبقة ثانية. ومع ذلك، تجنب إعادة وضع TISSEEL Lyo على طبقة TISSEEL Lyo المبلمرة الموجودة مسبقًا لأن TISSEEL Lyo لن تلتصق بطبقة مبلمرة. يجب تجنب الاستعمال المنفصل والمتسلسل لمكوّني TISSEEL Lyo.</p><p dir="RTL">&nbsp;</p><ul><li dir="RTL">أثناء العملية، سيقوم الجراح باستعمال TISSEEL Lyo على سطح الأنسجة المعنية، باستعمال جهاز خاص مزود للاستعمال. يضمن هذا الجهاز استعمال كميات متساوية من كلا المكوّنين في نفس الوقت - وهذا أمر مهم ليُحدث TISSEEL Lyo تأثيره الأمثل.</li><li dir="RTL">لإصلاح الفتق الشبكي، سيقوم الجراح بوضع TISSEEL باستعمال رذاذ أو قطرات لإصلاح الشبكة في مكانها.</li><li dir="RTL">سيقوم الموظفون المدرَّبون تدريبًا خاصًا من Baxter Healthcare بتدريب ممرضات غرفة العمليات والجراح على كيفية تحضير TISSEEL Lyo واستعماله بشكل صحيح، قبل إجراء العملية.</li><li dir="RTL">قبل وضع TISSEEL Lyo، يجب تجفيف مساحة سطح الجرح بالتقنيات القياسية (مثل التطبيق المتقطع للكمادات والمسحات واستعمال أجهزة الشفط).</li><li dir="RTL">يجب عدم استعمال الهواء أو الغاز المضغوط في تجفيف الموقع.</li></ul><ul><li dir="RTL">يجب رش TISSEEL فقط على مواقع الاستعمال المرئية.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>عند وضع </u></strong><strong><u>TISSEEL Lyo</u></strong><strong><u> باستعمال جهاز الرش، تأكد من إجراء الضغط والتأكد أن تكون المسافة من الأنسجة ضمن النطاق الموصى به من قبل الشركة المصنّعة على النحو التالي</u></strong><strong>:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="left" style="width:631px"><tbody><tr><td colspan="6"><p dir="RTL" style="text-align:center"><strong>الضغط والمسافة والأجهزة الموصى بها لاستعمال رش </strong><strong>TISSEEL Lyo</strong></p></td></tr><tr><td><p dir="RTL" style="text-align:center">الجراحة</p></td><td><p dir="RTL" style="text-align:center">أجهزة الرش التي سيتم استعمالها</p></td><td><p dir="RTL" style="text-align:center">أطراف أداة الوضع التي سيتم استعمالها</p></td><td><p dir="RTL" style="text-align:center">منظم الضغط الذي سيتم استعماله</p></td><td><p dir="RTL" style="text-align:center">المسافة الموصى بها من الأنسجة المستهدفة</p></td><td><p dir="RTL" style="text-align:center">ضغط الرش الموصى به</p></td></tr><tr><td rowspan="2"><p dir="RTL" style="text-align:center">الجرح المفتوح</p></td><td style="vertical-align:top"><p dir="RTL" style="text-align:center">أجهزة رش TISSEEL / Artiss</p></td><td><p dir="RTL" style="text-align:center">غير متاحة</p></td><td><p dir="RTL" style="text-align:center">EasySpray</p></td><td rowspan="2"><p dir="RTL" style="text-align:center">10-15 سم</p></td><td rowspan="2"><p dir="RTL" style="text-align:center">1.5-2.0 بار<br />(21.5-28.5 رطلاً لكل بوصة مربعة).</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL" style="text-align:center">أجهزة الرش TISSEEL / Artiss بعدد 10 عبوات</p></td><td><p dir="RTL" style="text-align:center">غير متاحة</p></td><td><p dir="RTL" style="text-align:center">EasySpray</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p dir="RTL" style="text-align:center">&nbsp;</p></td></tr><tr><td rowspan="6"><p dir="RTL" style="text-align:center">الإجراءات التنظيرية / طفيفة التوغل</p></td><td rowspan="6"><p dir="RTL" style="text-align:center">غير متاحة</p></td><td><p dir="RTL" style="text-align:center">جهاز Duplospray MIS Applicator بطول 20 سم</p></td><td rowspan="6"><p dir="RTL" style="text-align:center">جهاز Duplospray MIS Applicator بوزن 1.5 بار</p></td><td rowspan="6"><p dir="RTL" style="text-align:center">2-5 سم</p></td><td rowspan="6"><p dir="RTL" style="text-align:center">1.2-1.5 بار<br />(18-22 رطلاً لكل بوصة مربعة)</p></td></tr><tr><td><p dir="RTL" style="text-align:center">جهاز Duplospray MIS Applicator بطول 30 سم</p></td></tr><tr><td><p dir="RTL" style="text-align:center">جهاز Duplospray MIS Applicator بطول 40 سم</p></td></tr><tr><td><p dir="RTL" style="text-align:center">أجهزة الرش 360 لأداة التنظير الداخلية مع Snaplock</p></td></tr><tr><td><p dir="RTL" style="text-align:center">أجهزة الرش 360 لأداة التنظير مع حبل</p></td></tr><tr><td><p dir="RTL" style="text-align:center">طرف قابل للاستبدال</p></td></tr></tbody></table><p dir="RTL" style="text-align:center"><strong>&nbsp;</strong></p><p dir="RTL" style="text-align:center"><strong>&nbsp;</strong></p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL" style="text-align:center">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>عند رش </strong><strong>TISSEEL Lyo</strong><strong>، يجب مراقبة التغيرات في ضغط الدم والنبض وتشبع الأكسجين وثاني أكسيد الكربون في نهاية الزفير بسبب احتمال حدوث انصمام غازي أو هوائي <u>(انظر القسم 2)</u>.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كنت تأخذ </strong><strong>TISSEEL</strong><strong> أكثر مما ينبغي </strong></p><p dir="RTL">نظرًا لأن TISSEEL Lyo لا يتم استعماله إلا من قبل الجراح، فلا نعتقد أنه من الممكن استعمال الكثير.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستعمال في الأطفال</strong></p><p dir="RTL">لم تثبت سلامة المنتج وفاعليته لدى الأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع. إذا تفاقمت أيًا من الآثار الجانبية أو إذا لاحظت أي آثار جانبية غير مدرجة في هذه النشرة، فيرجى إخبار طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم تقييم الآثار الجانبية على أساس فئات التكرار التالية:</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>شائع جدًا:</strong> يصيب أكثر من 1 من كل 10.</p><p dir="RTL"><strong>شائع:</strong> يؤثر على 1 إلى 10 مستخدمين من كل 100.</p><p dir="RTL"><strong>غير شائع:</strong> يؤثر على 1 إلى 10 مستخدمين من كل 1000.</p><p dir="RTL"><strong>نادر:</strong> يؤثر على 1 إلى 10 مستخدمين من كل 10000.</p><p dir="RTL"><strong>نادر للغاية:</strong> يؤثر على أقل من 1 من كل 10000 مريض معالج.</p><p dir="RTL"><strong>غير معروف:</strong> لا يمكن تقدير التردد من البيانات المتاحة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لوحظت الآثار الجانبية التالية في العلاج بـ </strong><strong>TISSEEL Lyo</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:623px"><tbody><tr><td><p dir="RTL"><strong>المجالات العامة </strong></p></td><td><p dir="RTL"><strong>الأعراض الجانبية</strong></p></td><td><p dir="RTL"><strong>التكرار</strong></p></td></tr><tr><td><p dir="RTL">الالتهابات والأمراض الطفيلية</p></td><td><p dir="RTL">عدوى الجروح بعد الجراحة</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">اضطرابات الدم والجهاز الليمفاوي</p></td><td><p dir="RTL">زيادة منتجات تحلل الفيبرين</p></td><td><p dir="RTL">غير شائع</p></td></tr><tr><td rowspan="8"><p dir="RTL">اضطرابات الجهاز المناعي</p></td><td><p dir="RTL">تفاعلات فرط الحساسية</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">تفاعلات تحسسية (الحساسية)</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">صدمة الحساسية</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">الإحساس بوخز أو ارتعاش أو تنميل في الجلد</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">ضيق في الصدر</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">صعوبات في التنفس</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">مثير للحكة</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">احمرار الجلد</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">اضطرابات الجهاز العصبي</p></td><td><p dir="RTL">الاضطراب الحسي</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">اضطرابات القلب</p></td><td><p dir="RTL">زيادة معدل النبض أو انخفاضه</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td rowspan="6"><p dir="RTL">اضطرابات الأوعية الدموية</p></td><td><p dir="RTL">التخثر الوريدي الإبطي</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">انخفاض ضغط الدم</p></td><td><p dir="RTL">نادر</p></td></tr><tr><td><p dir="RTL">كدمات</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">فقاعات غازية في الأوعية الدموية *</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">جلطة دموية في الأوعية الدموية</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">انسداد شريان في المخ</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">اضطرابات الجهاز التنفسي والصدر</p></td><td><p dir="RTL">ضيق في التنفس</p></td><td><p dir="RTL">غير شائع</p></td></tr><tr><td rowspan="2"><p dir="RTL">اضطرابات الجهاز الهضمي</p></td><td><p dir="RTL">الغثيان</p></td><td><p dir="RTL">غير شائع</p></td></tr><tr><td><p dir="RTL">الانسداد المعوي</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td rowspan="3"><p dir="RTL">اضطرابات الجلد والأنسجة تحت الجلد</p></td><td><p dir="RTL">الطفح الجلدي</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">قشعريرة</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">ضعف الشفاء</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">الاضطرابات العضلية الهيكلية والنسيج الضام</p></td><td><p dir="RTL">ألم في الأطراف</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td rowspan="5"><p dir="RTL">الاضطرابات العامة وظروف الموقع الإدارة</p></td><td><p dir="RTL">الألم الناجم عن هذا الإجراء</p></td><td><p dir="RTL">غير شائع</p></td></tr><tr><td><p dir="RTL">ألم</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">زيادة درجة حرارة الجسم</p></td><td><p dir="RTL">شائع</p></td></tr><tr><td><p dir="RTL">احمرار الجلد</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td><p dir="RTL">التورم بسبب تراكم السوائل في أنسجة الجسم (الوذمة)</p></td><td><p dir="RTL">غير معروف</p></td></tr><tr><td rowspan="2"><p dir="RTL">الإصابة والتسمم والمضاعفات الإجرائية</p></td><td><p dir="RTL">تراكم السائل الليمفاوي أو سوائل الجسم الصافية الأخرى بالقرب من موقع العملية (التورم المصلي)</p></td><td><p dir="RTL">شائع للغاية</p></td></tr><tr><td><p dir="RTL">التورم السريع في الأدمة والأنسجة تحت الجلد والأغشية المخاطية وتحت المخاطية (الوذمة الوعائية)</p></td><td><p dir="RTL">غير معروف</p></td></tr></tbody></table><p dir="RTL">&nbsp;* حدث إدخال فقاعات هواء أو غاز في نظام الأوعية الدموية عند استعمال لاصقات الفايبرين مع أجهزة تستخدم هواء مضغوطًا أو غازًا؛&nbsp;يُعتقد أن هذا ناتج عن الاستعمال غير المناسب لجهاز الرش (على سبيل المثال عند ضغط أعلى من الموصى به وعلى مقربة من سطح الأنسجة).</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالات منعزلة، قد تتطور هذه التفاعلات إلى تفاعلات حساسية شديدة (الحساسية المفرطة). يمكن رؤية هذه التفاعلات بشكل خاص إذا تم تطبيق المستحضر بشكل متكرر، أو تم إعطاؤه للمرضى الذين أظهروا سابقًا حساسية تجاه أبروتينين أو أي مكون آخر من مكونات المنتج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">حتى إذا كان العلاج المتكرر باستخدام TISSEEL Lyo بالإمكان تحمله جيدًا، فإن إعطاء TISSEEL Lyo اللاحق أو تسريب أبروتينين قد يؤدي إلى تفاعلات حساسية شديدة (تحسس تأقي).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يدرك الفريق الجراحي المعالج جيدًا مخاطر حدوث تفاعلات من هذا النوع وسيقوم على الفور بمقاطعة وضع TISSEEL Lyo عند ظهور العلامات الأولى لفرط الحساسية. في حالة الأعراض الشديدة، قد تكون هناك حاجة لاتخاذ تدابير طارئة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يؤدي حقن TISSEEL Lyo في الأنسجة الرخوة إلى تلف الأنسجة المحلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يؤدي حقن TISSEEL Lyo في الأوعية الدموية (الأوردة أو الشرايين) إلى تكوين الجلطات (التخثر).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يزيد الاستعمال داخل الأوعية الدموية من احتمالية حدوث تفاعلات فرط الحساسية الحادة وشدتها في المرضى المعرضين للإصابة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لأن TISSEEL Lyo مشتق من البلازما من التبرعات بالدم، فلا يمكن استبعاد خطر الإصابة تمامًا. ومع ذلك، يتخذ المصنّعون تدابير عديدة لتقليل هذا الخطر (انظر القسم 2).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تحدث الأجسام المضادة ضد مكونات لاصقات الفايبرين في حالات نادرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا شعرت بتوعك بعد العملية، ولا تتطابق الأعراض مع تلك التي أخبرك بها طبيبك بالفعل، فعليك التحدث إلى طبيبك على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا كنت تعاني من أي آثار جانبية، فتحدث إلى طبيبك أو ممرضتك. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً عبر نظام الإبلاغ الوطني المُدرج أدناه. من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أي أثر (آثار) جانبية:</strong></p><p dir="RTL">&nbsp;</p><ul><li dir="RTL"><strong>المملكة العربية السعودية:</strong></li></ul><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهيئة العامة للغذاء والدواء : 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موقع الويب: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><ul dir="rtl"><li><strong>دول مجلس التعاون الخليجي الأخرى:</strong></li></ul><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يرجى الاتصال بالسلطة المختصة ذات الصلة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>يحفظ بعيدًا عن أنظار ومتناول أيدي الأطفال.</li><li>يخزن في درجة حرارة 2 إلى 25 درجة مئوية. لا يُجمّد.</li><li>يجب التخزين في العبوة الأصلية لحمايته من الضوء.</li><li>لا تستعمله بعد تاريخ انتهاء الصلاحية المذكور على الملصق.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما يحتويه </strong><strong>TISSEEL Lyo</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">عند التحضير، يحتوي 1 مل من كل محلول على ما يلي:</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ا</strong><strong>لمكون 1: محلول بروتين لاصق </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">المواد الفعّالة هي الفيبرينوجين البشري (كبروتين قابل للتخثر)، 72-110 مجم في 96-125 مجم من البروتين؛&nbsp;والأبروتينين (الاصطناعي)، 3000 وحدة دولية لكل مل. المكونات الأخرى هي الألبومين البشري، وإل-هيستيدين، والنياسيناميد، وبولي سوربات 80، وثنائي هيدرات سترات الصوديوم والماء للحقن. المكوّن الآخر هو الماء للحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ا</strong><strong>لمكوّن 2: محلول الثرومبين</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">المواد الفعالة هي الثرومبين البشري، 500 وحدة دولية، في 45-55 مجم بروتين.&nbsp;وثنائي هيدرات كلوريد الكالسيوم، 40 ميكرومول / لتر. المكونات الأخرى هي الزلال البشري وكلوريد الصوديوم والماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو </strong><strong>TISSEEL Lyo</strong><strong> وما محتويات العبوة</strong></p><p dir="RTL">يتم تعبئة جميع مكونات TISSEEL Lyo في حاويات زجاجية.</p><p dir="RTL">المكونات المجففة بالتجميد بيضاء أو صفراء قليلاً ولها اتساق على شكل مساحيق أو حبيبات؛&nbsp;وتكون المكونات السائلة عديمة اللون أو صفراء قليلاً.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتوفر TISSEEL في عبوات بأحجام 2 مل و4 مل و10 مل. قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>صاحب ترخيص التسويق: </strong></p><p dir="RTL"><strong>Baxter Medical Products GmbH</strong></p><p dir="RTL">Stella-Klein-L&ouml;w-Weg 15</p><p dir="RTL">1020 فيينا</p><p dir="RTL">النمسا</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المصنّعة:</strong></p><p dir="RTL"><strong>Takeda Manufacturing Austria AG</strong></p><p dir="RTL">Industriestrasse 67</p><p dir="RTL">1221 فيينا</p><p dir="RTL">النمسا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            نوفمبر 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TISSEEL Lyo – Powders and solvents for sealant
Two-Component Fibrin Sealant

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each TISSEEL Lyo contains 4 vials. The active ingredients are:

•	Sealer Protein Concentrate, Lyophilized for Sealer Protein Solution, Human, Vapour Heated, S/D treated
After reconstitution of the powder, 1 ml of Sealer Protein Solution contains:
Total protein 96 – 125 mg of which 72 – 110 mg is Fibrinogen (as clottable protein).

•	Aprotinin Solution, Solvent for Sealer Protein Concentrate Lyophilized, Aprotinin, synthetic 3000 KIU*/ml

•	Human Thrombin Lyophilized for Thrombin Solution, Human, Vapour Heated, S/D treated
After reconstitution of the powder, 1 ml of Thrombin Solution contains:
500 IU** of Thrombin in 45-55 mg of Total protein.

•	Calcium Chloride Solution, Solvent for Thrombin Powder
Calcium Chloride Dihydrate 40 μmol/ml

* KIU = Kallidinogenase Inactivator Unit
** One International Unit (IU) of Thrombin is defined as the activity contained in 0.0853 mg of the First International Standard for Human Thrombin or the First International Standard for Alpha Thrombin Human.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powders and solvents for fibrin sealant
One TISSEEL Lyo contains all the substances required for the preparation of the two fibrin sealant components and the kit for reconstitution and application (for details see Section 6.5. Nature and Contents of Containers).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Supportive treatment where standard surgical techniques are insufficient</p><p>- For improvement of hemostasis (see point 5.1)</p><p>- As a tissue glue to promote adhesion/sealing or as suture support:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - in gastrointestinal anastomoses</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - in neurosurgery where contact with cerebro-spinal fluid or dura mater may occur</p><p>&nbsp;</p><p>For mesh fixation in hernia repair, as an alternative or adjunct to sutures or staples.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TISSEEL Lyo is for topical (i.e., epilesional) use only, do not inject.</p><p>&nbsp;</p><p>TISSEEL must not be applied intravascularly (see Section 4.4).</p><p>&nbsp;</p><p>The use of TISSEEL Lyo is restricted to experienced surgeons who have been trained in the use of TISSEEL Lyo.</p><p>&nbsp;</p><p>Posology</p><p>The amount of TISSEEL Lyo to be applied and the frequency of application should always be oriented towards the underlying clinical needs of the patient.</p><p>&nbsp;</p><p>The dose to be applied is governed by variables including, but not limited to, the type of surgical intervention, the size of the area and the mode of intended application, and the number of applications.</p><p>&nbsp;</p><p>To avoid the formation of excess granulation tissue and to ensure gradual absorption of the solidified fibrin sealant, as thin a layer as possible of TISSEEL Lyo should be applied.</p><p>&nbsp;</p><p>If used for tissue adherence, it is recommended that the initial application cover the entire intended application area.</p><p>&nbsp;</p><p>Application of the product must be individualized by the treating physician. In clinical trials, the individual dosages have typically ranged from 4 to 20 ml.<em> </em>For some procedures, larger volumes may be required.</p><p>&nbsp;</p><p>The initial amount of the product to be applied at a chosen anatomic site or target surface area should be sufficient to entirely cover the intended application area. The application can be repeated, if necessary. However, avoid reapplication of TISSEEL Lyo to a pre-existing polymerized TISSEEL Lyo layer as TISSEEL Lyo will not adhere to a polymerized layer.</p><p>&nbsp;</p><p>As a guideline for the gluing of surfaces, 1 pack of TISSEEL Lyo 2&nbsp;ml (i.e. 1 ml Sealer Protein Solution plus 1 ml Thrombin Solution) will be sufficient for an area of at least 10&nbsp;cm<sup>2</sup>.</p><p>&nbsp;</p><p>When TISSEEL Lyo is applied by spraying, the same quantity will be sufficient to coat considerably larger areas, depending on the specific indication and the individual case.</p><p>&nbsp;</p><p>When TISSEEL Lyo is used for mesh fixation it may be applied as drops and/or by a spray technique depending on the preference of the surgeon. Usually the drops of TISSEEL are applied where surgeons routinely position staples and the layer of fibrin sealant achieved with spraying allows the entire mesh to be fixed in place without shrinking and folding.</p><p>&nbsp;</p><p>The quantity of TISSEEL Lyo required for mesh fixation depends on the mesh size selected and the recommended amount is the same for different application techniques. For example, 2-4 ml of reconstituted TISSEEL Lyo applied as a thin layer is suitable to adequately fix a standard size mesh of approximately 10 x 15 cm.</p><p>&nbsp;</p><p>When using the drop technique surgeons should apply TISSEEL Lyo at key anchor points for fixing the mesh (e.g. pubic tubercle in inguinal hernia repair) and at the margins of the mesh. Application by spray, either alone or in combination with drops, should cover the mesh uniformly with a thin layer.</p><p>&nbsp;</p><p>In inguinal hernia repair the mesh covering vascular structures and nerves can be fixed with TISSEEL Lyo alone using drops and/or spray.</p><p>&nbsp;</p><p><strong>Paediatric population</strong></p><p>&nbsp;</p><p>Safety and efficacy of the product in paediatric patients have not been established.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Method and route of administration</strong></p><p>&nbsp;</p><p>For topical (i.e. epilesional) use only, do not inject.</p><p>&nbsp;</p><p>Prepare the solutions as described at Section 6.6.</p><p>&nbsp;</p><p>Prior to application, TISSEEL must be warmed to 33-37&deg;C. Tisseel must not be exposed to temperatures above 37&deg;C and must not be microwaved.</p><p>&nbsp;</p><p>Separate, sequential application of the two components of TISSEEL must be avoided.</p><p>&nbsp;</p><p>In order to ensure optimal safe use of TISSEEL Lyo by spray application the following recommendations should be followed:</p><p>&nbsp;</p><p>In open wound surgery - a pressure regulator device that delivers a maximum pressure of no more than 2.0 bar (28.5 psi) should be used.</p><p>&nbsp;</p><p>In minimally invasive/laparoscopic procedures &ndash; a pressure regulator device that delivers a maximum pressure of no more than 1.5 bar (22 psi) and uses carbon dioxide gas only should be used.</p><p>&nbsp;</p><p>Prior to applying TISSEEL Lyo the surface area of the wound needs to be dried by standard techniques (e.g. intermittent application of compresses, swabs, use of suction devices).</p><p>&nbsp;</p><p>Do not use pressurized air or gas for drying the site.</p><p>&nbsp;</p><p>TISSEEL Lyo must be sprayed only onto application sites that are visible.</p><p>&nbsp;</p><p>TISSEEL Lyo should only be reconstituted and administered according to the instructions and with the devices recommended for this product (see section 6.6).</p><p>&nbsp;</p><p>For spray application, see sections 4.4 and 6.6 for specific recommendations on the required pressure and distance from tissue per surgical procedure and length of applicator tips.</p><p>&nbsp;</p><p>Application beyond the intended area should be avoided.</p><p>&nbsp;</p><p>If application is interrupted, clogging occurs immediately in the cannula. Replace the application cannula with a new one only immediately before application is resumed. If the aperture of the joining piece (Y connector) facing the cannula is clogged, use the spare joining piece provided in the package.</p><p>&nbsp;</p><p>In surgical procedures that require the use of minimal volumes of fibrin sealant, it is recommended to expel and discard the first few drops of product immediately before application, to ensure use of adequate mixed product (see Section 4.4).</p><p>&nbsp;</p><p>The sealer protein and thrombin solutions are denatured by alcohol, iodine, or heavy metal ions. If any of these substances have been used to clean the wound area, the area must be thoroughly rinsed before application of TISSEEL.</p><p>&nbsp;</p><p>After TISSEEL has been applied allow at least 2 minutes to achieve sufficient polymerization. Depending on type of use, the sealed parts may have to be fixed or held in the desired position for this time.</p><p>&nbsp;</p><p>Oxidised cellulose-containing preparations may reduce the efficacy of FS 500 and should not be used as carrier materials (see section 6.2).</p><p>&nbsp;</p><p>It is strongly recommended that every time Tisseel is applied to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.</p><p>&nbsp;</p><p>See Section 6.6 for more detailed instructions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TISSEEL Lyo must not be applied intravascularly. Intravascular application of TISSEEL Lyo may result in life-threatening thromboembolic events.

Known hypersensitivity to any constituents of the product, including aprotinin (see also section 4.4. Warnings).

TISSEEL Lyo alone is not indicated for the treatment for the treatment of active or spurting arterial or venous bleeding which is not controlled by conventional surgical techniques.

TISSEEL Lyo is not indicated to replace skin sutures intended to close surgical wound.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TISSEEL alone is not indicated for the treatment of severe or brisk arterial or venous bleeding which is not controlled by conventional surgical techniques.</p><p>&nbsp;</p><p>For epilesional use only. Do not apply intravascularly. Soft tissue injection of TISSEEL Lyo carries the risk of an anaphylactoid reaction and / or local tissue damage.</p><p>&nbsp;</p><p>Caution must be used when applying fibrin sealant using pressurized air or gas (See Section 4.2 and Section 4.8).</p><p>&nbsp;</p><p>Life threatening thromboembolic complications may occur if the preparation is unintentionally applied intravascularly.</p><p>&nbsp;</p><p>Intravascular application can lead to intravascular coagulation and may result in life-threatening thromboembolic events and might increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients.</p><p>&nbsp;</p><p>TISSEEL must be applied with caution to minimize any risk of intravascular application, for example in coronary bypass surgery. Because of the risk of intravascular injection, the product also must not be injected into highly vascularized tissue, such as nasal mucosa.</p><p>&nbsp;</p><p>In surgical applications that require the use of minimal volumes of fibrin sealant (e.g. pterygium surgery) the first few drops should be expelled and discarded before application to ensure adequate mixing of the sealer protein and thrombin solutions.</p><p>&nbsp;</p><p>Use of the first few drops in these procedures could result in the product being ineffective.</p><p>&nbsp;</p><p>In two retrospective, non-randomized studies in Coronary Artery Bypass Graft (CABG) surgery, patients that received fibrin sealant showed a statistically significant increased risk of mortality. While these studies could not provide a determination of a causal relationship the increased risk associated with the use of TISSEEL Lyo in these patients cannot be excluded. Therefore, additional care should be taken to avoid inadvertent intravascular administration of this product.</p><p>&nbsp;</p><p>Injection of Sealer Protein Solution and/or Thrombin Solution carries a risk of anaphylactoid reactions. Intravascular and intraventricular administration carries the additional risk of a thromboembolic complication. Both complications may be life-threatening. Therefore, care should be taken to ensure that TISSEEL Lyo and/or Thrombin Solution are only applied topically.</p><p>&nbsp;</p><p>Caution must be used when applying fibrin sealant using pressurized gas. Any application of pressurized gas is associated with a potential risk of air or gas embolism, tissue rupture, or gas entrapment with compression, which may be life-threatening or fatal.</p><p>&nbsp;</p><p><strong><u>Apply TISSEEL Lyo as a thin layer. Excessive clot thickness may negatively interfere with the product&rsquo;s efficacy and the wound healing process. </u></strong></p><p>&nbsp;</p><p><strong><u>Life-threatening/fatal air or gas embolism has occurred with the use of spray devices employing a pressure regulator to administer fibrin sealants. This event appears to be related to the use of the spray device at higher than recommended pressures and/or in close proximity to the tissue surface.&nbsp;The risk appears to be higher when fibrin sealants are sprayed with air, as compared to CO<sub>2</sub> and therefore cannot be excluded with TISSEEL Lyo when sprayed in open wound surgery.</u></strong></p><p>&nbsp;</p><p><strong><u>When applying TISSEEL Lyo using a spray device, be sure to use a pressure within the pressure range recommended by the spray device manufacturer (see table in section 6.6 for pressures and distances). </u></strong></p><p>&nbsp;</p><p><strong><u>TISSEEL Lyo spray application should only be used if it is possible to accurately judge the spray distance as recommended by the manufacturer. Do not spray closer than the recommended distances.</u></strong></p><p>&nbsp;</p><p><strong><u>When spraying TISSEEL Lyo, changes in blood pressure, pulse, oxygen saturation and end tidal CO<sub>2</sub> should be monitored because of the possibility of occurrence of air or gas embolism (also see section 4.2).</u></strong></p><p>&nbsp;</p><p>TISSEEL Lyo must not be used with the EasySpray/Spray Set system in enclosed body areas.</p><p>&nbsp;</p><p>Before the administration of TISSEEL Lyo, care is to be taken that parts of the body outside the designated application area are sufficiently protected/covered to prevent tissue adhesion at undesired sites.</p><p>&nbsp;</p><p>If fibrin sealants are applied in confined spaces, e.g. the brain or the spinal cord, the risk of compressive complications should be taken into account.</p><p>&nbsp;</p><p>As with any protein containing product, allergic type hypersensitivity reactions are possible. Signs of hypersensitivity reactions include hives, generalized urticaria, tightness of the chest, wheezing, hypotension and anaphylaxis. If these symptoms occur, the administration has to be discontinued immediately.</p><p>&nbsp;</p><p>Intravascular application might increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients.</p><p>&nbsp;</p><p>Manifestations of hypersensitivity reactions to TISSEEL observed include:</p><p>bradycardia, tachycardia, hypotension, flushing, bronchospasm, wheezing, dyspnoea, nausea, urticaria, angioedema, pruritus, erythema, paresthesia. Fatal anaphylactic reactions, including anaphylactic shock, have also been reported with TISSEEL see section 4.8).</p><p>&nbsp;</p><p>At the first sign or symptom of a hypersensitivity reaction, TISSEEL application must be stopped and medical care initiated. Remaining product must be removed from the site of application.</p><p>&nbsp;</p><p>Injection into the nasal mucosa must be avoided, as thromboembolic complications may occur in the area of the <em>arteria ophthalmica</em>.</p><p>&nbsp;</p><p>Injecting TISSEEL Lyo into tissue carries the risk of local tissue damage.</p><p>&nbsp;</p><p>TISSEEL Lyo contains synthetic aprotinin, a monomeric polypeptide known to be associated with anaphylactic reactions. Even in the case of strict local application of aprotinin there is a risk of anaphylactic reaction, particularly in the case of previous exposure. Aprotinin is included in TISSEEL for its antifibrinolytic properties. As with other aprotinin-containing products, the use of TISSEEL should be documented in the patient&rsquo;s records, pointing out that TISSEEL contains aprotinin.</p><p>&nbsp;</p><p>As synthetic aprotinin is structurally identical to bovine aprotinin the use of TISSEEL Lyo in patients with allergies to bovine proteins should be carefully evaluated.</p><p>&nbsp;</p><p>In case of shock, standard medical treatment for shock should be implemented.</p><p>&nbsp;</p><p>If fibrin sealants are applied in confined spaces, the risk of compressive complications should be taken into account.</p><p>&nbsp;</p><p>Sealer Protein Solution and Thrombin Solution are made from human plasma. The risk of transmitting an infectious agent has been reduced by screening plasma donors for prior exposure to certain viruses, by testing for the presence of certain current viral infections, and by inactivating and/or removing viruses.</p><p>&nbsp;</p><p>Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. This also applies to unknown or emerging viruses or other pathogens.</p><p>&nbsp;</p><p>The measures taken are considered effective for enveloped viruses such as HIV, HBV and HCV, and for the non-enveloped virus HAV.</p><p>&nbsp;</p><p>The measures taken may be of limited value against small non-enveloped viruses such as parvovirus B19. Parvovirus B19 infection may be serious for pregnant women (foetal infection) and for individuals with immunodeficiency or increased erythropoiesis (e.g., hemolytic anemia).</p><p>&nbsp;</p><p>It is strongly recommended that every time a patient receives a dose of TISSEEL Lyo, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.</p><p>&nbsp;</p><p>Oxidized cellulose-containing preparations should not be used with TISSEEL Lyo (See section 6.2 Incompatibilities).</p><p>&nbsp;</p><p>Adequate data are not available to support the use of this product in application through a flexible endoscope for treatment of bleeding or in vascular surgery.</p><p>&nbsp;</p><p>Safety and effectiveness of the product in pediatric patients has not been established as limited clinical study data are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No formal interaction studies have been performed. Similar to comparable products or thrombin solutions, the product may be denatured after exposure to solutions containing alcohol, iodine or heavy metals (e.g. antiseptic solutions). Such substances should be removed to the greatest possible extent before applying the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no adequate data from the use of TISSEEL in pregnant or lactating women.</p><p>&nbsp;</p><p>Physicians should carefully consider the potential risks and benefits for each specific patient before prescribing TISSEEL.</p><p>&nbsp;</p><p>No undesirable effects during pregnancy and lactation have been reported.</p><p>&nbsp;</p><p>See section 4.4 for information on Parvovirus B19 infection.</p><p>&nbsp;</p><p>The effects of TISSEEL Lyo on fertility have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the application site, bradycardia, bronchospasm, chills, dyspnoea, flushing, &nbsp;generalized urticaria, headache, hives, hypotension, lethargy, nausea, pruritus, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) may occur in rare cases in patients treated with fibrin sealants / hemostatics.</p><p>&nbsp;</p><p>In isolated cases, these reactions have progressed to severe anaphylaxis. Such reactions may especially be seen, if the preparation is applied repeatedly, or administered to patients known to be hypersensitive to aprotinin (see section 4.4) or any other constituents of the product.</p><p>&nbsp;</p><p>Even if a second treatment with TISSEEL Lyo was well tolerated, a subsequent administration of TISSEEL Lyo or systemic administration of aprotinin may result in severe anaphylactic reactions.</p><p>&nbsp;</p><p>In the event of hypersensitivity reactions the administration has to be discontinued immediately.</p><p>&nbsp;</p><p>Soft tissue injection of TISSEEL Lyo carries the risk of an anaphylactoid reaction and / or local tissue damage (see Section 4.4).</p><p>&nbsp;</p><p>Reactions to antibodies against components of fibrin sealant / haemostatic products may occur rarely.</p><p>&nbsp;</p><p>Inadvertent intravascular injection may result in thromboembolic events and disseminated intravascular coagulation, and there is also a risk of anaphylactic reaction (see section 4.4).</p><p><strong><em>&nbsp;</em></strong></p><p>For safety with respect to transmissible agents, see section 4.4.</p><p>&nbsp;</p><p>The following undesirable effects have been reported from clinical trials investigating the safety and efficacy of TISSEEL and from post-marketing experience with Baxter Fibrin Sealants. In these trials, TISSEEL was administered for adjunct haemostasis in cardiac, vascular total hip replacement and in liver and spleen surgeries. Other clinical trials included the sealing of lymphatic vessels in patients undergoing axillary lymph node dissection, sealing of colonic anastomosis and in durasealing in the posterior fossa. In these studies a total of 1146 patients were administered Baxter Fibrin sealant.</p><p>&nbsp;</p><p>For the undesirable effects reported from post-marketing experience with Baxter Fibrin Sealants, the frequency cannot be estimated from the available data.</p><p>&nbsp;</p><p>Very common (&sup3; 1/10)</p><p>Common (&sup3; 1/100 to &lt;1/10)</p><p>Uncommon (&sup3; 1/1,000 to &lt;1/100)</p><p>Rare (&sup3; 1/10,000 to &lt;1/1,000)</p><p>Very rare (&lt; 1/10,000)</p><p>Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:604px"><thead><tr><td style="vertical-align:top"><p><strong>System organ class </strong><strong>(SOC)</strong></p></td><td style="vertical-align:top"><p><strong>Preferred MedDRA Term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Postoperative wound infection</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Fibrin degradation products increased</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td rowspan="8" style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions*</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylactic reactions*</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylactic shock*</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Paresthesia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bronchospasm</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Wheezing</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Erythema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Sensory disturbance</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Bradycardia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Tachycardia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="7" style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Axillary vein thrombosis **</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Haematoma (NOS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Embolism arterial</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Air embolism***</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cerebral artery embolism</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cerebral infarction**</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Dyspnoea</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Intestinal obstruction</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Impaired healing</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Pain in an extremity</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Procedural pain</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pain</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Increased body temperature</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Flushing</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Injury, poisoning and procedural complications</p></td><td style="vertical-align:top"><p>Seroma</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td style="vertical-align:top"><p>Angioedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table><p><strong>* </strong>anaphylactic reactions and anaphylactic shock have included fatal outcomes.</p><p>** as a result of intravascular application into the superior petrosal sinus.</p><p>*** as with other fibrin sealants life-threatening/fatal air or gas embolism when using devices with pressurized air or gas occurred; this event appears to be related to an inappropriate use of the spray device (e.g. at higher than recommended pressure and in close proximity to the tissue surface.)</p><p>&nbsp;</p><p><strong><u>Class Reactions</u></strong></p><p>Other adverse reactions associated with the fibrin sealant/hemostatic class include:</p><p>Air or gas embolism when using devices with pressurized air or gas; this event appears to be related to the use of the spray device at higher than recommended pressures and in close proximity to the tissue surface. Manifestations of hypersensitivity include application site irritation, chest discomfort, chills, headache, lethargy, restlessness, and vomiting.</p><p>&nbsp;</p><p><strong><u>Reporting of suspected adverse reactions </u></strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the following national reporting system:</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:566px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p>&nbsp;</p><ul><li><strong>Other GCC States:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No case of overdose has been reported.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: local hemostatics, combinations, ATC code: B02BC30; tissue adhesives, ATC code: V03AK</p><p>&nbsp;</p><p>The fibrin adhesion system imitates the last phase of physiological blood coagulation. Conversion of fibrinogen into fibrin occurs by the splitting of fibrinogen into fibrin monomers and fibrinopeptides. The fibrin monomers aggregate and form a fibrin clot. Factor XIIIa, which is generated from Factor XIII by thrombin, crosslinks fibrin. Calcium ions are required for both, the conversion of fibrinogen and the crosslinkage of fibrin.</p><p>&nbsp;</p><p>As wound healing progresses, increased fibrinolytic activity is induced by plasmin and decomposition of fibrin to fibrin-degradation products is initiated. Proteolytic degradation of fibrin is inhibited by anti-fibrinolytics. Aprotinin is present in TISSEEL Lyo as an antifibrinolytic.</p><p>&nbsp;</p><p>Efficacy in haemostasis has been demonstrated in cardiopulmonary surgery, splenic surgery and neurosurgery.</p><p>&nbsp;</p><p>Use as tissue glue to promote adhesion/sealing or as suture support: Efficacy has been demonstrated in surgeries including gastrointestinal anastomoses and neurosurgical procedures where contact with cerebro-spinal fluid or dura mater can occur.</p><p>&nbsp;</p><p>Clinical studies demonstrating haemostasis, sealing, and tissue adhesion were conducted in at least 4,706 patients. These studies were performed in a multitude of surgical specialties, surgical procedures and applications techniques, including but not limited to haemostasis (n=1300), gastrointestinal anastomoses (n=1,114), neurosurgery (n=511).</p><p>&nbsp;</p><p>21 open and comparative clinical studies have also been conducted in 2625 patients to demonstrate the use of TISSEEL in mesh fixation during inguinal, femoral and incisional hernia repair by various open and laparoscopic techniques. TISSEEL was at least as effective as staples, tacks or sutures in mesh fixation during the repair of inguinal or femoral hernia using all the currently favoured surgical techniques. TISSEEL was at least as effective in repair of incisional hernias when judged by recurrence rates. In addition, the evidence demonstrated that there were no differences in postoperative complications between mesh fixation methods. In several studies the level of postoperative pain was significantly lower in the TISSEEL group.</p><p>&nbsp;</p><p>There is limited experience in children during cardiac surgery (age 4-134 months: n=14).</p><p>&nbsp;</p><p>Efficacy has been demonstrated also in fully heparinized patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TISSEEL Lyo is intended for epilesional use only. As a consequence, intravascular pharmacokinetic studies were not performed in man. Fibrin sealants / haemostatics are metabolized in the same way as endogenous fibrin by fibrinolysis and phagocytosis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No preclinical safety data are available for TISSEEL Lyo on acute toxicity, subacute and chronic toxicity, carcinogenicity or immune stimulation. None of the proteins contained in TISSEEL Lyo, nor calcium chloride have mutagenic effects.</p><p>Animal studies in rats have not shown any local toxicity.</p><p>High doses of aprotinin injected intravenously to pregnant rats had no embryotoxic or teratogenic effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.1.1&nbsp;&nbsp;&nbsp; Excipients of Sealer Protein Concentrate Lyophilized</strong></p><p>Human albumin</p><p>L-histidine</p><p>Niacinamide</p><p>Sodium citrate dihydrate</p><p>Polysorbate 80 (Tween 80)</p><p>Water for Injections</p><p>&nbsp;</p><p><strong>6.1.2&nbsp;&nbsp;&nbsp; Excipients of the Aprotinin Solution</strong></p><p>Water for Injections</p><p>&nbsp;</p><p><strong>6.1.3&nbsp;&nbsp;&nbsp; Excipients of Human Thrombin Lyophilized</strong></p><p>Human Albumin</p><p>Sodium Chloride</p><p>&nbsp;</p><p><strong>6.1.4&nbsp;&nbsp;&nbsp; Excipients of the </strong><strong>Calcium Chloride </strong><strong>Solution</strong></p><p>Water for Injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sealer Protein and Thrombin Solutions can be denatured following contact with solutions containing alcohol, iodine or heavy metals. Tisseel must not be mixed with other medicinal products</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TISSEEL Lyo has a shelf life of 3 years. 
Do not use after the expiry date.

Chemical and physical in-use stability of reconstituted Sealer Protein and Thrombin Solutions has been demonstrated for 6 hours at room temperature up to 37°C (reconstituted product must not be returned to the refrigerator).

From a microbiological point of view the product should be used immediately, unless the method of reconstitution precludes the risk of microbial contamination. If not used immediately, in-use storage times and conditions are the responsibility of the user.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at +2&deg;C to +25&deg;C (either in the refrigerator at +2&deg;C to 8&deg;C or at controlled room temperature (no exceeding +25&deg;C).</p><p>Do not freeze.</p><p>Store in the original container to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>All components are filled into glass containers conforming to EP requirements. The vials containing Sealer Protein Concentrate are equipped with a magnetic spin propeller.</p><p>&nbsp;</p><p>TISSEEL Lyo is available in presentations of 2 ml, 4 ml and 10 ml.</p><p>&nbsp;</p><p><u>Each TISSEEL Lyo Kit contains the following:</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 vial containing Sealer Protein Concentrate Lyophilized;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 vial containing Human Thrombin Lyophilized;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 vial containing synthetic Aprotinin Solution;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 vial containing Calcium Chloride Solution;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 kit for reconstitution and application</p><p>&nbsp;</p><p><strong>6.5.1&nbsp;&nbsp;&nbsp; Kit for Reconstitution and Application</strong></p><p>&nbsp;</p><p>Each kit contains one single-sterile set of devices for reconstitution under nonsterile conditions, and one double-sterile set of devices for application under sterile conditions.</p><p>&nbsp;</p><p>The set for reconstitution includes 2 disposable needles plus one blue-scaled disposable syringe and one black-scaled disposable syringe.</p><p>&nbsp;</p><p>The set for application includes 2 disposable needles plus one blue-scaled disposable syringe and one black-scaled disposable syringe, one DUPLOJECT Two-Syringe Clip, 2 Joining Pieces and 4 Application Needles.</p><p>&nbsp;</p><p>For details on reconstitution and application see the following section.</p><p>&nbsp;</p><p>The sets of devices are sterile and non-pyrogenic in unopened and undamaged packages. Sterilised by exposure to ethylene oxide.</p><p><strong>For single use only. Do not re-sterilise.</strong></p><p>CE<strong> <sub>0297</sub></strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>&nbsp;</p><p>Before the administration of TISSEEL Lyo, care must be taken that parts of the body outside the desired application area are sufficiently covered to prevent tissue adhesion at undesired sites</p><p>&nbsp;</p><p>To prevent TISSEEL Lyo from adhering to gloves and instruments, wet these with saline before contact.</p><p>&nbsp;</p><p><strong>Preparation and reconstitution</strong></p><p>&nbsp;</p><p>Prior to reconstitution of the fibrin sealant components, clean the rubber stoppers of all vials should be cleansed. Direct contact of disinfectant and product must be avoided (see Section 4.5).</p><p>&nbsp;</p><p><u>I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preparation of Sealer Protein Solution (First Component)</u></p><p>&nbsp;</p><p>Sealer Protein Concentrate Lyophilized is dissolved with the Aprotinin Solution to form Sealer Protein Solution.</p><p>&nbsp;</p><p>Sealer Protein Concentrate Lyophilized is reconstituted using the FIBRINOTHERM warming and stirring device (recommended method). Alternatively, a sterile water bath at a temperature of 33 - 37&deg;C can be used.</p><p>&nbsp;</p><p><u>Reconstitution using the FIBRINOTHERM device:</u></p><p>&nbsp;</p><p>The FIBRINOTHERM device maintains a constant temperature of 37&deg;C. It also shortens the dissolution time of the Sealer Protein Concentrate Lyophilized by rotating the magnetic stirrer contained in each Sealer Protein Concentrate Lyophilized vial.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Place the vials containing Sealer Protein Concentrate Lyophilized and Aprotinin Solution into the appropriate openings of the FIBRINOTHERM device and preheat the vials for approximately 3 minutes.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer the Aprotinin Solution into the vial containing the Sealer Protein Concentrate Lyophilized using one canula and the blue-scaled syringe provided in the single-sterile kit for reconstitution. Place Sealer Protein Concentrate Lyophilized vial into stirring well of the FIBRINOTHERM device (use an appropriate adaptor, if necessary) and stir until complete dissolution. Reconstitution is complete as soon as no particles are visible anymore when holding the vial against the light. If particles are present, keep on stirring the solution at 37&deg;C for a few more minutes until complete dissolution. Turn off the magnetic stirrer when dissolution is complete.</p><p>&nbsp;</p><p><strong>Note: Excessive stirring might compromise product quality</strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the Sealer Protein Solution at 37&deg;C without stirring if it is not used immediately. To ensure homogeneity stir or swirl briefly before drawing up the Sealer Protein Solution into the blue-scaled syringe provided in the double sterile kit for application.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw the reconstituted Sealer Protein Solution from the vial under sterile conditions.</p><p>&nbsp;</p><p>For further instructions please refer to the instructions for use of the FIBRINOTHERM device.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Reconstitution using a water bath:</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preheat the vials containing the Sealer Protein Concentrate Lyophilized and the Aprotinin Solution for approximately 3 minutes in a water bath at a temperature of 33 - 37&deg;C. (Heating beyond 37&deg;C must be avoided)</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer the Aprotinin Solution into the vial containing the Sealer Protein Concentrate Lyophilized using one needle and the blue-scaled syringe provided in the single-sterile kit for reconstitution.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Return the Sealer Protein Concentrate Lyophilized vial to the water bath at 33 - 37&deg;C for one minute.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swirl briefly but avoid frothing. Then return the vial to the water bath and check periodically for complete dissolution. Reconstitution is complete as soon as no particles are visible when holding the vial against the light. If particles are present, keep the vial at a temperature of 33 - 37&deg;C for a few more minutes and agitate until complete dissolution.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the Sealer Protein Solution at 33 - 37&deg;C after complete dissolution if it is not used immediately. To ensure homogeneity swirl briefly before drawing up the solution into the blue-scaled syringe provided in the double sterile kit for application.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdraw the reconstituted Sealer Protein Solution from the vial under sterile conditions.</p><p>&nbsp;</p><p><strong>Note</strong>: When using a water bath for reconstitution instead of the FIBRINOTHERM device special precautions have to be taken against submersing the vial, particularly the septum, to avoid possible contamination.</p><p>&nbsp;</p><p><u>II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preparation of the Thrombin Solution &ndash; (Second Component)</u></p><p>&nbsp;</p><p>The Human Thrombin Lyophilized is dissolved with the Calcium Chloride Solution to form the Thrombin Solution. Transfer the contents of the Calcium Chloride Solution vial into the Thrombin vial. Use the second needle and the black-scaled syringe provided in the single-sterile kit for reconstitution.</p><p>&nbsp;</p><p>Swirl briefly to dissolve the lyophilized substance. To warm the Thrombin Solution either the FIBRINOTHERM device or a water bath can be used. Keep the Thrombin Solution at 33 - 37&deg;C until use. Prior to use, draw up the Thrombin Solution from the vial using the second needle and the black-scaled syringe provided in the double-sterile kit for application.</p><p>&nbsp;</p><p><strong>Note:</strong> &nbsp;&nbsp; Syringes and needles used for the reconstitution of one component must not be reused for reconstitution of the other component, as this would lead to premature solidification of that component in the vial or syringe.</p><p>&nbsp;</p><p><u>III.&nbsp;&nbsp;&nbsp; Use of reconstituted fibrin sealant components</u></p><p>&nbsp;</p><p>Both fibrin sealant components must be used within 6 hours of reconstitution.</p><p>&nbsp;</p><p><strong>Administration</strong></p><p><strong>&nbsp;</strong></p><p>The Sealer Protein and the Thrombin Solutions should be clear or slightly opalescent. Do not use solutions which are cloudy or have deposits. Reconstituted products should be inspected visually for particulate matter and discoloration prior to administration.</p><p>&nbsp;</p><p>Prior to administration, TISSEEL Lyo should be warmed to 33 - 37&deg;C.</p><p>&nbsp;</p><p>For application, place the two single-use syringes with the reconstituted Sealer Protein Solution and Thrombin Solution have to be clipped into the DUPLOJECT Two-Syringe Clip and connect this assembly to be connected to a joining piece and an application needle. All necessary devices are provided in the double-sterile kit for application.</p><p>&nbsp;</p><p>The common plunger of the DUPLOJECT Two-Syringe Clip ensures that equal volumes are fed through the joining piece before being mixed in the application needle and ejected.</p><p><em><u><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_i1025" type="#_x0000_t75"
 style='width:453.75pt;height:268.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/sanadm/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="605" height="358" alt="" vspace="0" hspace="0" border="0" style="width:605px;height:358px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/sanadm/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" /></u></em></p><p>&nbsp;</p><p><u>Operating instructions</u></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Place the two syringes with the Sealer Protein Solution and with Thrombin Solution into the clip. Both syringes must be filled with equal volumes.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Connect the nozzles of both syringes to the joining piece ensuring that they are firmly fixed. Secure the joining piece by fastening the safety strap to the DUPLOJECT Two-Syringe Clip. Should the safety strap tear, use the spare joining piece. If none is available, further use is still possible but tightness of the connection needs to be ensured to prevent any risk of leaking.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fit an application needle onto the joining piece.</p><p>Do not expel the air remaining inside the joining piece or application needle until you start the actual application as the aperture of the needle may clog otherwise.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Apply the mixed Sealer Protein -Thrombin Solution on to the recipient surface or surfaces of the parts to be sealed.</p><p>&nbsp;</p><p>For surgical procedures that require minimal volumes of fibrin sealant do not use the first few drops of TISSEEL Lyo (see Sections 4.2 and 4.4)</p><p>&nbsp;</p><p>If application of the fibrin sealant components is interrupted, clogging occurs immediately in the needle. Replace the application needle with a new one only immediately before application is resumed. If the apertures of the joining piece are clogged, use the spare joining piece provided in the package.</p><p>&nbsp;</p><p><strong>Note:</strong> After blending of the sealant components, the fibrin sealant starts to set within seconds on account of the high Thrombin concentration (500 IU/ml).</p><p>&nbsp;</p><p>Application is also possible with other accessories supplied by BAXTER that are particularly suited for, e.g., minimally invasive surgery, application to large or difficult-to-access areas. When using these application devices, strictly follow the Instructions for Use of the devices.</p><p>&nbsp;</p><p>After two components have been applied, approximate the wound areas. Fix or hold the glued parts with continuous gentle pressure in the desired position to ensure that the setting fibrin sealant adheres firmly to the surrounding tissue. Allow at least 2 minutes to achieve sufficient polymerization.</p><p>&nbsp;</p><p>In certain applications, biocompatible material, such as collagen fleece, is used as a carrier substance or for reinforcement.</p><p>&nbsp;</p><p><strong><u>Spray application</u></strong></p><p>When applying TISSEEL Lyo using a spray device be sure to use a pressure and a distance from tissue within the ranges recommended by the manufacturer as follows:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:631px"><tbody><tr><td colspan="6"><p style="text-align:center"><strong>Recommended pressure, distance and devices for spray application of TISSEEL Lyo</strong></p></td></tr><tr><td><p style="text-align:center">Surgery</p></td><td style="width:102px"><p style="text-align:center">Spray set to be used</p></td><td style="width:105px"><p style="text-align:center">Applicator tips to be used</p></td><td style="width:110px"><p style="text-align:center">Pressure regulator to be used</p></td><td style="width:89px"><p style="text-align:center">Recommended distance from target tissue</p></td><td><p style="text-align:center">Recommended spray pressure</p></td></tr><tr><td rowspan="2"><p style="text-align:center">Open wound</p></td><td style="vertical-align:top; width:102px"><p style="text-align:center">Tisseel / Artiss Spray Set</p></td><td style="width:105px"><p style="text-align:center">n.a.</p></td><td style="width:110px"><p style="text-align:center">EasySpray</p></td><td rowspan="2" style="width:89px"><p style="text-align:center">10-15cm</p></td><td rowspan="2"><p style="text-align:center">1.5-2.0 bar<br />(21.5-28.5 psi).</p></td></tr><tr><td style="vertical-align:top; width:102px"><p style="text-align:center">Tisseel / Artiss Spray Set 10 pack</p></td><td style="width:105px"><p style="text-align:center">n.a.</p></td><td style="width:110px"><p style="text-align:center">EasySpray</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p style="text-align:center">&nbsp;</p></td></tr><tr><td rowspan="6"><p style="text-align:center">Laparoscopic/ minimally invasive procedures</p></td><td rowspan="6" style="width:102px"><p style="text-align:center">n.a.</p></td><td style="width:105px"><p style="text-align:center">Duplospray MIS Applicator 20cm</p></td><td rowspan="6" style="width:110px"><p style="text-align:center">Duplospray MIS Regulator 1.5 bar</p></td><td rowspan="6" style="width:89px"><p style="text-align:center">2-5 cm</p></td><td rowspan="6"><p style="text-align:center">1.2-1.5 bar</p><p style="text-align:center">(18-22 psi)</p></td></tr><tr><td style="width:105px"><p style="text-align:center">Duplospray MIS Applicator 30cm</p></td></tr><tr><td style="width:105px"><p style="text-align:center">Duplospray MIS Applicator 40cm</p></td></tr><tr><td style="width:105px"><p style="text-align:center">Spray Set 360 Endoscopic Applicator with Snap Lock</p></td></tr><tr><td style="width:105px"><p style="text-align:center">Spray Set 360 Endoscopic Applicator with Tether</p></td></tr><tr><td style="width:105px"><p style="text-align:center">Replaceable tip</p></td></tr></tbody></table><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p style="text-align:center">&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong><u>When spraying the TISSEEL Lyo, changes in blood pressure, pulse, oxygen saturation and end tidal CO<sub>2 </sub>should be monitored because of the possibility of occurrence of air or gas embolism (see sections 4.2 and 4.4).</u></strong></p><p>&nbsp;</p><p><strong>Disposal</strong></p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Medical Products GmbH
Stella-Klein-Low-Weg 15
1020 Vienna
Austria
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>